Pikesville, MD, United States of America

Michael S Lebowitz

This inventor holds 4 USPTO granted patents and 9 published patent applications. Top assignees: Johns Hopkins University, Athanor Biosciences, Inc.. Active years: 2000-2023.

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2000-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael S. Lebowitz

Introduction

Michael S. Lebowitz is a notable inventor based in Pikesville, MD, with a significant impact in the field of biotechnology. He holds four patents, showcasing his dedication to advancing medical science through innovative solutions. His work primarily focuses on bacteriophage-based vaccines and immune system regulation.

Latest Patents

Lebowitz's latest patents include groundbreaking developments in bacteriophage-based vaccines. One of his patents describes engineered bacteriophage and methods for their formation. These multivalent bacteriophage can incorporate multiple different exogenous polypeptides on the surface of the capsid head. The vaccines he has developed can include engineered bacteriophage that exhibit immunogenic exogenous polypeptides, which are free of nucleic acids encoding the exogenous polypeptides. Another significant patent involves cell compositions that comprise molecular complexes designed to modify immune responses. These compositions can be utilized to detect and regulate antigen-specific T cells and serve as therapeutic agents for various disorders, including allergies and autoimmune diseases.

Career Highlights

Throughout his career, Michael S. Lebowitz has worked with prestigious organizations, including The Johns Hopkins University and Athanor Biosciences, Inc. His contributions to these institutions have been instrumental in advancing research and development in the field of immunology and biotechnology.

Collaborations

Lebowitz has collaborated with notable colleagues, including Jonathan Schneck and Sean O'Herrin. These partnerships have further enriched his research and innovation efforts.

Conclusion

Michael S. Lebowitz's work exemplifies the spirit of innovation in biotechnology, particularly in the development of vaccines and immune system therapies. His contributions continue to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…